Documents

In this section, you will find reviews and digests regarding the status of antiviral research and development on various diseases of interest, along with other types of reports and listings.


To buy a document, click on the corresponding button (following the description). You will be transferred to a secure online PayPal® transaction site for payment through your PayPal® account or credit card. Upon payment, you will receive an email that will provide you with a link to download your document. (Payments by cheques also accepted)

Please note that this link is time-sensitive and will expire after 24 h!

 

Documents available below:

1. Companies in Antivirals 2018
2. HCV Drugs and Vaccines - Development Status 2017
3. RSV R&D status 2017
4. Zika virus R&D status 2018
5. Chikungunya virus R&D status 2018
6. Dengue virus R&D status 2017
7. MERS and SARS viruses R&D status 2017
8. Ebola and Filoviruses R&D status 2018
9. Norovirus R&D status 2018
10. Published Lead Compounds with Antiviral Activity

 

1. Companies in Antivirals 2018

- Last update Jan. 2018
- More than 345 companies listed, worldwide distribution
- Running active programs in antiviral drugs and vaccines discovery and development
- Company name, website, physical address, email address, phone/fax numbers, contact names, and virus programs
- Provided as an Excel spreadsheet

- Price: $295 US

 

2. HCV Drugs and Vaccines - Development Status 2017

- Simplified overview of current HCV market and products
- Focus: products on the market and in pharma pipeline
- 80 pages, 11 Tables (pdf format)
- Over 115 pharmaceutical organizations covered
- All Direct-Acting Antiviral Agents (DAAs) on the market
- All DAAs in development, targeting HCV NS5A, NS3/4B, or NS5B
- Vaccines and other immune-related products in development
- Novel viral targets
- Future directions and perspectives

- Last update April 2017

- See Table of Contents in "News" section

- Price: $375 US

 

3. RSV R&D status 2017

- Last update Dec. 2017
- 142 products listed, all stages of development
- More than 110 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel document

- Price:
$195 US

 

4. Zika virus R&D status 2018

- Last update Jan. 2018
- 65 products listed, all stages of development
- More than 59 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel document

- Price:
$100 US

 

5. Chikungunya virus R&D status 2018

- Last update Jan. 2018
- 25 products listed, all stages of development
- More than 25 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel spreadsheet

- Price:
$100 US

 

6. Dengue virus R&D status 2017

- Last update Dec. 2017
- 104 products listed, all stages of development
- More than 76 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel document

- Price:
$100 US

 

7. MERS and SARS viruses R&D status 2017

- Last update Dec. 2017
- 64 products listed, all stages of development
- More than 56 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel spreadsheet

- Price:
$100 US

 

8. Ebola and Filoviruses R&D status 2018

- Last update Feb. 2018
- 117 products listed, all stages of development
- More than 72 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel document

- Price:
$230 US

 

9. Norovirus R&D status 2018

- Last update Jan. 2018
- 15 products listed, all stages of development
- More than 17 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel spreadsheet

- Price:
$100 US

 

10. Published Lead Compounds with Antiviral Activity

- Over 300 compounds included, developed against 15 families of Virus
- Excel format with information selected to provide a quick overview of compound's key attributes
- Organizations (originators) and compound’s designation, plus References
- Mechanisms of action when deciphered (including several new targets)

- Activity on viral target and/or virus replication in cell-based assays (IC50, EC50)
, along with Cytotoxicity

- Classified by target Virus types/Families

- Chemical structures (including several novel drug scaffolds)

- Price:
$295 US